Novo Nordisk (NVO) Stock May Trade Below Fair Value After GLP 1 Expansion Plans
Novo Nordisk has seen its share price fall sharply in recent years, and the drop is prompting fresh questions about what investors are currently paying for its earnings. With the…
TR
By Tom Reyes · Markets Editor
Oct 9 20:51 ETSource: Simply Wall Street
From the source
Read at simplywall.stNovo Nordisk (NVO) Stock May Trade Below Fair Value After GLP 1 Expansion Plans
Novo Nordisk has seen its share price fall sharply in recent years, and the drop is prompting fresh questions about what investors are currently paying for its earnings. With the stock under pressure and growth ambitions around weight-loss treatments in focus, the valuation now hinges on how resilient and repeatable those profits look.
